Abstract
Infective endocarditis (IE) in elderly patients is a serious disease with significant morbidity and mortality. IE presents unique diagnostic and therapeutic challenges in the elderly. A heightened index of suspicion is necessary due to the atypical presentations of IE among the elderly. Underlying degenerative valvular disease, mitral valve prolapse, and presence of a prosthetic valve are important predisposing risk factors for IE in the elderly. IE in the elderly is somewhat more common in men. The mitral valve is affected somewhat more frequently compared with the aortic valve. Streptococci and staphylococci are the predominant organisms, recovered in approximately 80% of elderly patients with IE. The presence of calcific valvular lesions and prosthetic valves often confound echocardiographic findings in the elderly. Aggressive diagnostic and therapeutic approaches are mandatory for a favorable outcome of IE in this group of patients.
Similar content being viewed by others
References and Recommended Reading
Hoesley CJ, Cobbs CG: Endocarditis at the millennium. J Infect Dis 1999, 179(Suppl 2):S360-S365.
Steckelberg JM, Melton LJ, 3rd, Ilstrup DM, et al.: Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 1990, 88:582–588.
Fefer P, Raveh D, Rudensky B, et al.: Changing epidemiology of infective endocarditis: a retrospective survey of 108 cases, 1990–1999. Eur J Clin Microbiol Infect Dis 2002, 21:432–437. A recent series of IE cases from the period 1990 through 1999 reporting 108 cases that met the von Reyn or Duke criteria. Among patients with native valves, nonrheumatic valvular heart disease of the elderly was the most common underlying factor.
Von Reyn CF, Levy BS, Arbeit RD, et al.: Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981, 94:505–518.
Dhawan VK: Infective endocarditis in elderly patients. [see comments.]. Clin Infect Dis 2002, 34:806–812. A recent review of IE in the elderly.
Cunha BA, Gill MV, Lazar JM: Acute infective endocarditis. Diagnostic and therapeutic approach. Infect Dis Clin North Am 1996, 10:811–834.
Gagliardi JP, Nettles RE, McCarty DE, et al.: Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database. Clin Infect Dis 1998, 26:1165–1168.
Netzer RO, Zollinger E, Seiler C, et al.: Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria. Clin Infect Dis 1999, 28:933–935.
Pomerance A: Pathogenesis of aortic stenosis and its relation to age. Br Heart J 1972, 34:569–574.
Pomerance A: Pathological and clinical study of calcification of the mitral valve ring. J Clin Pathol 1970, 23:354–361.
Felder RS, Nardone D, Palac R: Prevalence of predisposing factors for endocarditis among an elderly institutionalized population. Oral Surg Oral Med Oral Pathol 1992, 73:30–34.
Werner GS, Schulz R, Fuchs JB, et al.: Infective endocarditis in the elderly in the era of transesophageal echocardiography: clinical features and prognosis compared with younger patients. Am J Med 1996, 100:90–97.
Leport C, Bure A, Leport J, et al.: Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. Lancet 1987, 1:748.
Lessing MP, Crook DW, Bowler IC, et al.: Native-valve endocarditis caused by Staphylococcus lugdunensis. Q J Med 1996, 89:855–858.
Fernandez-Guerrero ML, Verdejo C, Azofra J, et al.: Hospitalacquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 1995, 20:16–23.
Terpenning MS, Bradley SF, Wan JY, et al.: Kauffman CA. Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc 1994, 42:1062–1069.
Terpenning MS, Buggy BP, Kauffman CA: Infective endocarditis: clinical features in young and elderly patients. Am J Med 1987, 83:626–634.
Habte-Gabr E, January LE, Smith IM: Bacterial endocarditis: the need for early diagnosis. Geriatrics 1973, 28:164–170.
Applefeld MM, Hornick RB: Infective endocarditis in patients over age 60. Am Heart J 1974, 88:90–94.
Thell R, Martin FH, Edwards JE: Bacterial endocarditis in subjects 60 years of age and older. Circulation 1975, 51:174–182.
Tenenbaum MJ, Kaplan MH: Infective endocarditis in the elderly: an update. Geriatrics 1984, 39:121–123.
Gantz NM: Geriatric endocarditis: avoiding the trend toward mismanagement. Geriatrics 1991, 46:66–68.
Selton-Suty C, Hoen B, Grentzinger A, et al.: Clinical and bacteriological characteristics of infective endocarditis in the elderly. Heart 1997, 77:260–263.
Cantrell M, Yoshikawa TT: Infective endocarditis in the aging patient. Gerontology 1984, 30:316–326.
Durack DT, Lukes AS, Bright DK: New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994, 96:200–209.
Li JS, Sexton DJ, Mick N, et al.: Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633–638. The article outlines the recent modifications to the Duke criteria for the clinical diagnosis of IE.
Bayer AS: Infective endocarditis. Clin Infect Dis 1993, 17:313–320.
Millar B, Moore J, Mallon P, et al.: Molecular diagnosis of infective endocarditis--a new Duke’s criterion. Scand J Infect Dis 2001, 33:673–680.
Lisby G, Gutschik E, Durack DT: Molecular methods for diagnosis of infective endocarditis. Infect Dis Clin North Am 2002, 16:393–412.
Pedersen WR, Walker M, Olson JD, et al.: Value of transesophageal echocardiography as an adjunct to transthoracic echocardiography in evaluation of native and prosthetic valve endocarditis. Chest 1991, 100:351–356.
Daniel WG, Mugge A, Martin RP, et al.: Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991, 324:795–800.
Sexton DJ, Tenenbaum MJ, Wilson WR, et al.: Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis 1998, 27:1470–1474.
Olaison L, Schadewitz K: Enterococcal endocarditis in Sweden, 1995–1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 2002, 34:159–166. The largest series of enterococcal endocarditis so far presented. A 5-year nationwide prospective study in Sweden during 1995 through 1999 identified enterococcal endocarditis in 93 episodes. Mortality during treatment was 16%, the relapse rate was 3%, and clinical cure was achieved in the remaining 81% of the patients. Clinical cure was achieved with a median duration of cell wall-active antimicrobial therapy of 42 days combined with an aminoglycoside (median treatment time, 15 days). The study suggests that in many enterococcal endocarditis episodes, duration of aminoglycoside therapy could probably be shortened to 2 to 3 weeks.
DiNubile MJ: Abbreviated therapy for right-sided Staphylococcus aureus endocarditis in injecting drug users: the time has come? Eur J Clin Microbiol Infect Dis 1994, 13:533–534.
Small PM, Chambers HF: Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990, 34:1227–1231.
Ruiz ME, Guerrero IC, Tuazon CU: Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid. Clin Infect Dis 2002, 35:1018–1020.
Steckelberg JM, Murphy JG, Ballard D, et al.: Emboli in infective endocarditis: the prognostic value of 6echocardiography. Ann Intern Med 1991, 114:635–640.
Larbalestier RI, Kinchla NM, Aranki SF, et al.: Acute bacterial endocarditis. Optimizing surgical results. Circulation 1992, 86:1168–1174.
Olaison L, Pettersson G: Current best practices and guidelines indications for surgical intervention in infective endocarditis. Infect Dis Clin North Am 2002, 16:453–475.
Miyaji K, Murakami A, Suematsu Y, et al.: Video-assisted cardioscopy for infectious endocarditis. Pediatr Cardiol 2002, 23:562–563.
Dajani AS, Taubert KA, Wilson W, et al.: Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997, 96:358–366.
Watanakunakorn C, Burkert T: Infective endocarditis at a large community teaching hospital, 1980–1990. A review of 210 episodes. Medicine (Baltimore) 1993, 72:90–102.
Robbins N, DeMaria A, Miller MH: Infective endocarditis in the elderly. South Med J 1980, 73:1335–1338.
Zamorano J, Sanz J, Moreno R, et al.: Better prognosis of elderly patients with infectious endocarditis in the era of routine echocardiography and nonrestrictive indications for valve surgery. J Am Soc Echocardiography 2002, 15:702–707. A large series of patients with IE studied echocardiographically. Thirty-one patients 65 years or older were compared with 72 patients younger than 65 years of age. Degenerative heart disease was seen more frequently in the elderly (22.5% vs 2.7%, P = 0.003). Despite other similar clinical features, it took longer to diagnose older patients (7.2 +/- 6.2 vs 3.2 +/- 3.5 days, P < 0.001). Enterococcus infected the aged more often (32.2% vs 13.1%, P = 0.001). During hospitalization, heart failure and embolization tended to be more common in the elderly and the younger group, respectively. There were no significant differences in the incidence of anatomic complications, the need for operation, and overall mortality.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dhawan, V.K. Infective endocarditis in elderly patients. Curr Infect Dis Rep 5, 285–292 (2003). https://doi.org/10.1007/s11908-003-0004-z
Issue Date:
DOI: https://doi.org/10.1007/s11908-003-0004-z